Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New BBB-crossing FMR1-based AAVphp constructs for treatment of Fragile X syndrome

Oct. 28, 2021

CRISP/Cas9 modulation of utrophin as a strategy to treat DMD

Oct. 27, 2021

Stealth BioTherapeutics describes compounds for treating mitochondrial disease

Oct. 27, 2021

Discovery of novel VMAT2 inhibitor with potential for the treatment of tardive dyskinesia

Oct. 27, 2021

Impaired axon guidance is early sign of Wolfram syndrome

Oct. 26, 2021

Tremeau to develop novel deuterium-enriched etoricoxib compound for acute pain

Oct. 26, 2021

Gluk2-targeted siRNA-based gene therapy for drug-resistant temporal lobe epilepsy

Oct. 26, 2021

Repurposing bumetanide for the treatment of APOE4-related AD

Oct. 26, 2021

CHD8 haploinsufficiency leads to seizure phenotype

Oct. 25, 2021

Purnovate selects PNV-5030 as lead compound in pain program

Oct. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...